The Board of Ergomed has said today that Rolf Stahel, who has served as Chairman since April 2014, will retire from the Board at the expiry of his three year term of office on March 31, 2017.
In turn, he will be succeeded with immediate effect by Peter George, who has been a non-executive director of Ergomed since July 2014. The company said it intends to appoint a further non-executive director to the Board in due course.
Dr. Miroslav Reljanović, CEO, said:
“I should like to thank Rolf for his invaluable insights and experience over the last few years which have helped shape Ergomed, both through the IPO and subsequently. We appreciate the advance notice of his intention to retire from the Board as it allows for an orderly succession. With that in mind, we are fortunate to have on the Board a suitable successor in Peter, who I have enjoyed working with and I look forward to the value he can add in the years ahead.”
Rolf Stahel said:
“I have enjoyed my time pre and post IPO at Ergomed. I congratulate Peter George on his well merited appointment as Chairman Designate. Peter will be taking over this new responsibility for a company that continues to show strong financial performance and I am looking forward to the future of Ergomed with confidence.”